<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Zhang W</submitter><pubmed_abstract>Pancreatic cancer (PC) is the most lethal human cancer, with less than 10% 5-year survival. Pancreatic premalignancy is a genetic and epigenomic disease and is linked to PC initiation. Pancreatic premalignant lesions include pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN), and mucinous cystic neoplasm (MCN), with pancreatic acinar-to-ductal metaplasia (ADM) as the major source of pancreatic premalignant lesions. Emerging evidence reveals that an epigenetic dysregulation is an early event in pancreatic tumorigenesis. The molecular mechanisms of epigenetic inheritance include chromatin remodeling; modifications in histone, DNA, and RNA; non-coding RNA expression; and alternative splicing of RNA. Changes in those epigenetic modifications contribute</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>1024151</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9978013</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Epigenetic reprogramming in pancreatic premalignancy and clinical implications.</pubmed_title><pmcid>PMC9978013</pmcid><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Xie K</pubmed_authors><pubmed_authors>Jiang T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epigenetic reprogramming in pancreatic premalignancy and clinical implications.</name><description>Pancreatic cancer (PC) is the most lethal human cancer, with less than 10% 5-year survival. Pancreatic premalignancy is a genetic and epigenomic disease and is linked to PC initiation. Pancreatic premalignant lesions include pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN), and mucinous cystic neoplasm (MCN), with pancreatic acinar-to-ductal metaplasia (ADM) as the major source of pancreatic premalignant lesions. Emerging evidence reveals that an epigenetic dysregulation is an early event in pancreatic tumorigenesis. The molecular mechanisms of epigenetic inheritance include chromatin remodeling; modifications in histone, DNA, and RNA; non-coding RNA expression; and alternative splicing of RNA. Changes in those epigenetic modifications contribute</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-21T23:45:48.943Z</modification><creation>2025-04-05T19:16:43.279Z</creation></dates><accession>S-EPMC9978013</accession><cross_references><pubmed>36874143</pubmed><doi>10.3389/fonc.2023.1024151</doi></cross_references></HashMap>